Previous Seminar
Innovative Approaches to Clinical Trials
Robert M. Califf, M.D.
Vice Chancellor for Clinical Research
Director
Duke Translational Medicine Institute
Professor of Medicine
Duke University Medical Center
Resources
Thursday, March 8, 2012
10:00 a.m. – noon
Building 45 (Natcher), Rooms E1-E2
NIH Campus | Bethesda, Maryland
Presented by
Office of Disease Prevention
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse
NCI Division of Cancer Prevention
About the Seminar
With the science of clinical trials evolving quickly, Dr. Califf discussed the role and value nonrandomized controlled trials have in medical research and clinical trials. The number of therapeutic interventions is growing, and the need for clear scientific evidence that these interventions work is mounting. Recent emphasis on evidence-based medicine, patient-centered outcomes research, learning, and accountable healthcare systems underscores the fact that most clinical trials fail to provide the evidence needed to inform medical decision-making. The need for a balance between commercial interests and public health is warranted.
About Robert M. Califf, M.D.
Dr. Califf is the vice chancellor for clinical research and director of the Duke Translational Medicine Institute, and professor of medicine in the Division of Cardiology at the Duke University Medical Center in Durham, North Carolina. He is also the editor in chief of American Heart Journal and is the author or coauthor of more than 1,000 peer-reviewed articles. Dr. Califf also serves as a contributing editor for www.theheart.org , an online information resource for healthcare professionals involved in the diagnosis and management of cardiovascular disease.
He has served on the Cardiorenal Advisory Panel of the U.S. Food and Drug Administration and the Pharmaceutical Roundtable of the Institute of Medicine. He currently serves as co-chair of the Clinical Trials Transformation Initiative, a public-private partnership focused on improving the clinical trials system, and as chair of the Clinical Research Forum, an organization of academic health and science system leaders focused on the improvement of the clinical research enterprise. A member of the National Advisory Council on Aging, he also serves on the Secretary’s Advisory Council on Human Research for the U.S. Department of Health and Human Services. Dr. Califf received his undergraduate degree from Duke University and his M.D. from Duke University Medical School.
Raising the Bar: Engineering Optimized Behavioral Interventions for Increased Public Health Impact
Linda M. Collins, Ph.D.
Tuesday, March 26, 2013
Helping Smokers with Behavioral Health Comorbidity Requires a National Effort
Jill Marie Williams, M.D.
Tuesday, April 16, 2013
Designing and Analyzing Randomized Controlled Trials in the Prevention of Mental Disorders and Drug Abuse
C. Hendricks Brown, Ph.D.
Thursday, May 9, 2013
Bridging the Gap between What Health Professionals Should Do to Help Smokers Quit and What They Actually Do: What is the Role of Public Health Care Workers and the NIH?
Steven Schroeder, M.D.
Tuesday, June 18, 2013
Evidence-Informed Factors for Promoting Psychological Resilience in the U.S. Military
Terri Tanielian, M.A.
Thursday, September 20, 2012
Cancer Care: The Patient’s Role, Palliative Care, and Implications for Health Policy
Amy Berman, R.N.
Friday, August 3, 2012
Communicating Possible Harms and Benefits of Treatment and Lifestyle
Professor David Spiegelhalter, OBE, FRS
Wednesday, June 20, 2012
The Evidence-to-Practice Gap: Teaching Clinicians Evidence-based
Medicine
W. Scott Richardson, M.D.
Thursday, May 17, 2012
The Pressure To Get It Right: Biases in Biomedical Research
John Ioannidis, M.D., D.Sc.
Monday, March 19, 2012
Innovative Approaches to Clinical Trials
Robert M. Califf, M.D.
Thursday, March 8, 2012
View All Previous Seminars